{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:35:07Z","timestamp":1782995707823,"version":"3.54.5"},"reference-count":26,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Acinetobacter\u00a0baumannii (AB), particularly carbapenem-resistant strains (CRAB), is a major cause of difficult-to-treat infections associated with substantial mortality. Contemporary data from Central and Eastern Europe remain scarce. We aimed to characterize the epidemiology, clinical features, and survival of patients with AB bloodstream infection in a multicenter Polish cohort. Methods: We conducted a retrospective multicenter study including consecutive adults with microbiologically confirmed AB bloodstream infection. Clinical and demographic data, comorbidities, infection origin, and antimicrobial treatments were collected. Outcomes included all-cause in-hospital mortality and infection-attributed mortality. Survival was assessed using Kaplan\u2013Meier curves and log-rank tests, while factors associated with death were examined with univariable and multivariable Cox regression. Results: Among 245 patients with CRAB bloodstream infection, overall mortality was 69.4%, and infection-attributed mortality reached 51.8%. Most infections (75.1%) were hospital-acquired. In univariable analyses, male sex (HR = 0.66; p = 0.008) and colistin-based therapy (HR = 0.71; p = 0.037) were associated with improved survival. Conversely, hospital-acquired infection (HR = 0.43; p &lt; 0.001) and acute kidney injury (HR = 1.40; p = 0.038) were linked to higher mortality. In the multivariable model, male sex remained protective (HR = 0.61; p = 0.006), while hospital-acquired infection (HR = 0.35; p &lt; 0.001) and COVID-19 (HR = 1.64; p = 0.049) independently predicted death. After adjustment, no other comorbidities or antimicrobial regimens showed significant associations. Conclusions: In this multicenter cohort of patients with CRAB bloodstream infection, mortality remained extremely high. Hospital-acquired infection, acute kidney injury, and COVID-19 were strong independent predictors of poor outcomes, whereas male sex was associated with better survival. Although colistin-containing therapy appeared beneficial in univariable analysis, this effect did not persist after adjustment, underscoring potential confounding. These findings highlight the urgent need for early recognition, optimized antimicrobial strategies, and prevention of healthcare-associated spread to improve outcomes in CRAB bacteremia.<\/jats:p>","DOI":"10.3390\/jcm15020527","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T15:33:16Z","timestamp":1767886396000},"page":"527","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Epidemiology of Carbapenem-Resistant Acinetobacter baumannii Bloodstream Infections in Poland: A Multi-Center Study of Mortality, Risk Factors and Drug Resistance"],"prefix":"10.3390","volume":"15","author":[{"given":"Agnieszka","family":"Kuncka","sequence":"first","affiliation":[{"name":"Department of Anaesthesiology and Intensive Therapy, Mazovian Brodnowski Hospital, 03-242 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1457-9899","authenticated-orcid":false,"given":"Patrycja","family":"Le\u015bnik","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Wroclaw Medical University, 50-556 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2164-8079","authenticated-orcid":false,"given":"Jaros\u0142aw","family":"Janc","sequence":"additional","affiliation":[{"name":"Department of Emergency Medical Service, Faculty of Nursing and Midwifery, Wroclaw Medical University, 50-556 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Dzier\u017canowska-Fangrat","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology and Immunology, Children\u2019s Memorial Health Institute, 04-730 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5772-7839","authenticated-orcid":false,"given":"Martyna","family":"Bia\u0142a","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Liver Diseases and Acquired Immune Deficiences, Faculty of Medicine, Wroclaw Medical University, 51-149 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Ko\u0142at-Brodecka","sequence":"additional","affiliation":[{"name":"Hospital Infection Prevention and Control Team, University Clinical Hospital of the Military Medical Academy-Central Veterans Hospital, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9672-6011","authenticated-orcid":false,"given":"Natalia","family":"S\u0142abisz","sequence":"additional","affiliation":[{"name":"Department of Preclinical Sciences, Pharmacology and Medical Diagnostics, Faculty of Medicine, Wroclaw University of Science and Technology, 50-370 Wroc\u0142aw, Poland"},{"name":"Department of Laboratory Diagnostics, 4th Military Clinical Hospital, 50-981 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-0037-1599225","article-title":"Infections Due to Acinetobacter baumannii in the ICU: Treatment Options","volume":"38","author":"Lynch","year":"2017","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"100077","DOI":"10.1016\/j.infpip.2020.100077","article-title":"Control and management of multidrug resistant Acinetobacter baumannii: A review of the evidence and proposal of novel approaches","volume":"2","author":"Weinberg","year":"2020","journal-title":"Infect. Prev. Pract."},{"key":"ref_3","first-page":"491","article-title":"Emergence of antimicrobial resistance among Acinetobacter species: A global threat","volume":"22","author":"Clark","year":"2016","journal-title":"Curr. Opin. Crit. Care"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.3892\/etm.2017.4137","article-title":"Prognosis of patients with Acinetobacter baumannii infection in the intensive care unit: A retrospective analysis","volume":"13","author":"Xiao","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"ref_5","unstructured":"(2017, November 01). Guidelines for the Prevention and Control of Carbapenem-Resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in Health Care Facilities, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK493061\/."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Kumar, S., Anwer, R., and Azzi, A. (2021). Virulence Potential and Treatment Options of Multidrug-Resistant (MDR) Acinetobacter baumannii. Microorganisms, 9.","DOI":"10.3390\/microorganisms9102104"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ayoub Moubareck, C., and Hammoudi Halat, D. (2020). Insights into Acinetobacter baumannii: A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen. Antibiotics, 9.","DOI":"10.3390\/antibiotics9030119"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"107167","DOI":"10.1016\/j.ijantimicag.2024.107167","article-title":"Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: New data from CREDIBLE-CR with an updated meta-analysis","volume":"63","author":"Gill","year":"2024","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Nutman, A., Temkin, E., Wullfhart, L., Schechner, V., Schwaber, M.J., and Carmeli, Y. (2023). Acinetobacter baumannii bloodstream infections: A nationwide study in Israel. Microorganisms, 11.","DOI":"10.3390\/microorganisms11092178"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Lan, M., Dongmei, K., Guodong, S., Haifeng, Y., Guofeng, C., Mengting, C., and Xiaoyun, F. (2024). Risk factors for bacteremic pneumonia and mortality (28-day mortality) in patients with Acinetobacter baumannii bacteremia. BMC Infect. Dis., 24.","DOI":"10.1186\/s12879-024-09335-8"},{"key":"ref_12","unstructured":"(2025, October 15). Antimicrobial Resistance Surveillance in Europe 2023\u20132021 Data 2023. European Centre for Disease Prevention and Control. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/antimicrobial-resistance-surveillance-europe-2023-2021-data."},{"key":"ref_13","first-page":"16734","article-title":"Molecular epidemiology and clinical significance of carbapenemase genes in carbapenem-resistant Acinetobacter baumannii isolates in southern Poland","volume":"134","author":"Serwacki","year":"2024","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Appaneal, H.J., Lopes, V.V., LaPlante, K.L., and Caffrey, A.R. (2022). Treatment, Clinical Outcomes, and Predictors of Mortality among a National Cohort of Admitted Patients with Acinetobacter baumannii Infection. Antimicrob. Agents Chemother., 66.","DOI":"10.1128\/aac.01975-21"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Nutman, A., Levi, G.D., Keren-Paz, A., Schwartz, D., Masarwa, S., Schechner, V., and Carmeli, Y. (2023). Active surveillance for carbapenem-resistant Acinetobacter baumannii (CRAB) carriage. Microbiol. Spectr., 11.","DOI":"10.1128\/spectrum.03146-23"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.36519\/idcm.2025.608","article-title":"Risk factors for mortality in patients treated with colistin monotherapy for carbapenem-resistant Acinetobacter baumannii infections","volume":"3","author":"Katip","year":"2025","journal-title":"Infect. Dis. Clin. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7795096","DOI":"10.1155\/2021\/7795096","article-title":"Colistin-Induced Acute Kidney Injury and the Effect on Survival in Patients with Multidrug-Resistant Gram-Negative Infections: Significance of Drug Doses Adjusted to Ideal Body Weight","volume":"2021","author":"Arrayasillapatorn","year":"2021","journal-title":"Int. J. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Tamma, P.D., Heil, E.L., Justo, J.A., Mathers, A.J., Satlin, M.J., and Bonomo, R.A. (2024). Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections. Clin. Infect. Dis., ciae403.","DOI":"10.1093\/cid\/ciae403"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S1473-3099(23)00184-6","article-title":"Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: A multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)","volume":"23","author":"Kaye","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Huang, C., Chen, I., and Tang, T. (2022). Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis. J. Clin. Med., 11.","DOI":"10.3390\/jcm11113239"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.cmi.2023.05.036","article-title":"Colistin plus meropenem versus colistin alone for invasive infections caused by carbapenem-resistant Acinetobacter baumannii: A rapid systematic review of randomized controlled trials using Bayesian meta-analysis","volume":"29","author":"Maraolo","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zhan, Y., Mao, W., Zhao, C., Lu, D., Chen, C., Hu, W., and Yang, Q. (2024). Comparison of cefiderocol and colistin-based regimens for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: A systematic review with meta-analysis and trial sequential analysis. BMC Infect. Dis., 24, Erratum in BMC Infect. Dis.\u00a02024, 24, 1086. https:\/\/doi.org\/10.1186\/s12879-024-09979-6.","DOI":"10.1186\/s12879-024-09899-5"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Pais, T., Jorge, S., and Lopes, J.A. (2024). Acute Kidney Injury in Sepsis. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25115924"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s13054-024-05167-9","article-title":"Korean Sepsis Alliance (KSA) investigator. Epidemiology of sepsis-associated acute kidney injury in critically ill patients: A multicenter, prospective, observational cohort study in South Korea","volume":"28","author":"Song","year":"2024","journal-title":"Crit. Care"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.2147\/IDR.S469244","article-title":"Nosocomial, Healthcare-Associated, and Community-Acquired Acinetobacter baumannii in China: Clinical Characteristics, Antimicrobial Resistance Patterns and Risk Factors Associated with Carbapenem Resistance","volume":"17","author":"Li","year":"2024","journal-title":"Infect. Drug Resist."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Mun, S.J., Kim, S.H., Kim, H.T., Moon, C., and Wi, Y.M. (2022). The epidemiology of bloodstream infection contributing to mortality: The difference between community-acquired, healthcare-associated, and hospital-acquired infections. BMC Infect. Dis., 22.","DOI":"10.1186\/s12879-022-07267-9"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/2\/527\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T09:27:59Z","timestamp":1768382879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/2\/527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["jcm15020527"],"URL":"https:\/\/doi.org\/10.3390\/jcm15020527","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]}}}